Cargando…
Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison’s Disease
BACKGROUND: No reliable biomarkers exist to guide glucocorticoid (GC) replacement treatment in autoimmune Addison’s disease (AAD), leading to overtreatment with alarming and persistent side effects or undertreatment, which could be fatal. OBJECTIVE: To explore changes in gene expression following di...
Autores principales: | Sævik, Åse Bjorvatn, Wolff, Anette B, Björnsdottir, Sigridur, Simunkova, Katerina, Hynne, Martha Schei, Dolan, David William Peter, Bratland, Eirik, Knappskog, Per M, Methlie, Paal, Carlsen, Siri, Isaksson, Magnus, Bensing, Sophie, Kämpe, Olle, Husebye, Eystein S, Løvås, Kristian, Øksnes, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853175/ https://www.ncbi.nlm.nih.gov/pubmed/33553982 http://dx.doi.org/10.1210/jendso/bvaa202 |
Ejemplares similares
-
Residual Corticosteroid Production in Autoimmune Addison Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2020) -
Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function
por: Åkerman, Anna-Karin, et al.
Publicado: (2023) -
SAT296 Ambulatory 24-hour Tissue Microdialysis Of Cortisol And Metabolites, A Tool For Precision Management In Addison’s Disease
por: Botusan, Ileana, et al.
Publicado: (2023) -
SAT285 Biomarkers For Cardiovascular Disease And Inflammation Are Altered In Autoimmune Addison's Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2023) -
Multisteroid LC–MS/MS assay for glucocorticoids and androgens and its application in Addison's disease
por: Methlie, Paal, et al.
Publicado: (2013)